CMR Surgical
Uresha Patel has a diverse work experience spanning various roles and industries. Uresha is currently working at CMR Surgical as the Clinical Development Engineering Lead, having joined the company in November 2021. Prior to this role, they served as a Senior Clinical Development Engineer and a Bioengineer at the same company. Uresha was responsible for clinical education and played a key role in the development of surgical technology.
Before joining CMR Surgical, Uresha worked at the University of Nottingham as a Research Associate and was involved in a short project focused on capturing the impact of TexGen outside of academia. Uresha conducted surveys, literature reviews, and engaged with users of the software.
Uresha'searlier experience includes being a PhD student at The University of Nottingham, where they specialized in the manufacture and structural characterization of resorbable phosphate-glass microspheres for bone repair applications. Uresha also worked at the Motor Neurone Disease Association in the Research Grants Team.
Uresha pursued a Master of Science degree in Biomaterials at the University of Manchester, where they gained knowledge in current clinically used biomaterials and their assessment. Uresha also completed a Bachelor of Medical Science degree at the University of Birmingham, where they conducted research on the effects of various liquefiers on the physico-chemical properties of an orthopedic cement.
Uresha began their career in 2007 as a Sales Associate at H.Samuel and Pondens Mill.
Uresha Patel completed their education with a Doctor of Philosophy (PhD) from the University of Nottingham in 2016. Prior to that, they obtained a Master of Science (MSc) in Biomaterials from The University of Manchester in 2013. In 2012, Uresha received a BMedSc Honours degree in Biomedical Material Science from the University of Birmingham. Uresha attended Northampton High School for their secondary education.
This person is not in the org chart
CMR Surgical
3 followers
CMR Surgical is the UK’s leading surgical robotics company. Its next-generation robotic system, Versius, has been designed to significantly increase the volume and range of supported procedures, making the benefits of robotic minimal access surgery universally accessible and affordable.